Lincoln Park Capital

InVivo Therapeutics Announces Purchase Agreement for up to $15 Million with Lincoln Park Capital

January 26, 2018 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced that it has entered into a common stock…